B-12
Regenerative Medicine Unit
7F
0701
Development of new technology for
the manufacturing, standardization and
application of stem cell-based products
Regenerative medicine based on stem-cell technology can possibly treat irreversibly dysfunctional tissues or organs that medicine cannot treat currently. However, the realization of regenerative medicine has faced some significant obstacles, such as cell preparation methods, product standardization, and the costs of manufacturing. The aim of our department is to develop new technologies to manufacture and standardize stem-cell-based products for the advancement of regenerative medicine.
Responsible Departments
Department of Stem Cells
and Applied Medicine
Research Partner
ROHTO Pharmaceutical Co., Ltd.
Project Members
Principal Investigator
Endowed Chair Associate Professor
Department of Stem Cells and Applied Medicine
Members
Professor
Department of Ophthalmology
Professor
Department of Biomedical Informatics
Assistant Professor
Department of Ophthalmology
Endowed Chair Assistant Professor
Department of Stem Cells and Applied Medicin
Associate Professor (Lecturer)
Department of Ophthalmology
Visiting Researcher
ROHTO Pharmaceutical Co., Ltd.
Visiting Researcher
ROHTO Pharmaceutical Co., Ltd.
Visiting Researcher
ROHTO Pharmaceutical Co., Ltd.
Visiting Researcher
ROHTO Pharmaceutical Co., Ltd.
Links
Department of Stem Cells and Applied Medicine, Osaka University
http://www.stemed.med.osaka-u.ac.jp/index-e.html
ROHTO Pharmaceutical Co., Ltd.
https://www.rohto.co.jp/global/